Literature DB >> 27109379

Exploring the binding of d(GGGT)4 to the HIV-1 integrase: An approach to investigate G-quadruplex aptamer/target protein interactions.

Veronica Esposito1, Luciano Pirone2, Luciano Mayol1, Emilia Pedone2, Antonella Virgilio1, Aldo Galeone1.   

Abstract

The aptamer d(GGGT)4 (T30923 or T30695) forms a 5'-5' dimer of two stacked parallel G-quadruplexes, each characterized by three G-tetrads and three single-thymidine reversed-chain loops. This aptamer has been reported to exhibit anti-HIV activity by targeting the HIV integrase, a viral enzyme responsible for the integration of viral DNA into the host-cell genome. However, information concerning the aptamer/target interaction is still rather limited. In this communication we report microscale thermophoresis investigations on the interaction between the HIV-1 integrase and d(GGGT)4 aptamer analogues containing abasic sites singly replacing thymidines in the original sequence. This approach has allowed the identification of which part of the aptamer G-quadruplex structure is mainly involved in the interaction with the protein.
Copyright © 2016 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Aptamer T30695; Circular dichroism; G-quadruplex; HIV-1 integrase; Microscale thermophoresis; NMR

Mesh:

Substances:

Year:  2016        PMID: 27109379     DOI: 10.1016/j.biochi.2016.04.013

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  9 in total

Review 1.  In What Ways Do Synthetic Nucleotides and Natural Base Lesions Alter the Structural Stability of G-Quadruplex Nucleic Acids?

Authors:  Janos Sagi
Journal:  J Nucleic Acids       Date:  2017-10-18

Review 2.  G-Quadruplex-Binding Proteins: Promising Targets for Drug Design.

Authors:  Huiling Shu; Rongxin Zhang; Ke Xiao; Jing Yang; Xiao Sun
Journal:  Biomolecules       Date:  2022-04-29

3.  Antiproliferative Effects of the Aptamer d(GGGT)4 and Its Analogues with an Abasic-Site Mimic Loop on Different Cancer Cells.

Authors:  Antonella Virgilio; Annalisa Pecoraro; Daniela Benigno; Annapina Russo; Giulia Russo; Veronica Esposito; Aldo Galeone
Journal:  Int J Mol Sci       Date:  2022-05-25       Impact factor: 6.208

4.  The Sam-Sam interaction between Ship2 and the EphA2 receptor: design and analysis of peptide inhibitors.

Authors:  Flavia Anna Mercurio; Concetta Di Natale; Luciano Pirone; Roberta Iannitti; Daniela Marasco; Emilia Maria Pedone; Rosanna Palumbo; Marilisa Leone
Journal:  Sci Rep       Date:  2017-12-12       Impact factor: 4.379

Review 5.  Aptamers: Uptake mechanisms and intracellular applications.

Authors:  Sorah Yoon; John J Rossi
Journal:  Adv Drug Deliv Rev       Date:  2018-07-06       Impact factor: 15.470

Review 6.  Aptamers in Virology-A Consolidated Review of the Most Recent Advancements in Diagnosis and Therapy.

Authors:  Tejabhiram Yadavalli; Ipsita Volety; Deepak Shukla
Journal:  Pharmaceutics       Date:  2021-10-09       Impact factor: 6.321

7.  Improvement of the activity of the anti-HIV-1 integrase aptamer T30175 by introducing a modified thymidine into the loops.

Authors:  Antonella Virgilio; Teresa Amato; Luigi Petraccone; Francesca Esposito; Nicole Grandi; Enzo Tramontano; Raquel Romero; Shozeb Haider; Isabel Gomez-Monterrey; Ettore Novellino; Luciano Mayol; Veronica Esposito; Aldo Galeone
Journal:  Sci Rep       Date:  2018-05-10       Impact factor: 4.379

Review 8.  Oligonucleotide aptamers: promising and powerful diagnostic and therapeutic tools for infectious diseases.

Authors:  Qin Pan; Fengling Luo; Min Liu; Xiao-Lian Zhang
Journal:  J Infect       Date:  2018-05-07       Impact factor: 6.072

9.  Probing the Importance of the G-Quadruplex Grooves for the Activity of the Anti-HIV-Integrase Aptamer T30923.

Authors:  Veronica Esposito; Francesca Esposito; Antonietta Pepe; Isabel Gomez Monterrey; Enzo Tramontano; Luciano Mayol; Antonella Virgilio; Aldo Galeone
Journal:  Int J Mol Sci       Date:  2020-08-06       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.